The notion that animals could be used as predictive models in science has been influenced by relatively recent developments in the fields of complexity science, evolutionary and developmental biology, genetics, and evolutionary biology in general. Combined with empirical evidence, which has led scientists in drug development to acknowledge that a new, nonanimal model is needed, a theory—not a hypothesis—has been formed to explain why animals function well as models for humans at lower levels of organization but are unable to predict outcomes at higher levels of organization. Trans-Species Modeling Theory (TSMT) places the empirical evidence in the context of a scientific theory and thus, from a scientific perspective, the issue of where animals can and cannot be used in science has arguably been settled. Yet, some in various areas of science or science-related fields continue to demand that more evidence be offered before the use of animal models in medical research and testing be abandoned on scientific grounds. In this article, I examine TSMT, the empirical evidence surrounding the use of animal models, and the opinions of experts. I contrast these facts with the opinions and positions of those that have a direct or indirect vested interest—financial or otherwise—in animal models. I then discuss the ethical implications regarding research constructed to find cures and treatments for humans.
KeywordsAnimal ModelBiological Complex SystemEvolutionPredictive ValueTrans-Species Modeling Theory
Greek, R. (2008) Letter. Dogs, Genes and Drugs. American Scientist, 96, 4.
Shanks, N., Greek, R. and Greek, J. (2009) Are Animal Models Predictive for Humans? Philosophy, Ethics, and Humanities in Medicine, 4, 2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 19146696 http://dx.doi.org/10.1186/1747-5341-4-2
Greek, R. and Greek, J. (2010) Is the Use of Sentient Animals in Basic Research Justifiable? Philosophy, Ethics, and Humanities in Medicine, 5, 14. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 20825676 http://dx.doi.org/10.1186/1747-5341-5-14
Greek, R., Hansen, L.A. and Menache, A. (2011) An Analysis of the Bateson Review of Research Using Nonhuman Primates. Medicolegal and Bioethics, 1, 3-22. http://www.dovepress.com/an-analysis-of-the-bateson-review-of-research-using-nonhuman -primates-peer-reviewed-article-MB
Greek, R. and Shanks, N. (2011) Complex Systems, Evolution, and Animal Models. Studies in History and Philosophy of Biological and Biomedical Sciences, 42, 542-544. http://www.ncbi.nlm.nih.gov/pubmed/22035727
Greek, R., Shanks, N. and Rice, M.J. (2011) The History and Implications of Testing Thalidomide on Animals. The Journal of Philosophy, Science & Law, 11. http://www6.miami.edu/ethics/jpsl/archives/all/TestingThalidomide.html
Greek, R. (2012) Animal Models and the Development of an HIV Vaccine. Journal of AIDS & Clinical Research, S8, 1. http://www.omicsonline.org/2155-6113/2155-6113-S8-001.php?aid=5787
Greek, R. (2012) Book Review. Zoobiquity: What Animals Can Teach Us about Health and the Science of Healing. Animals, 2, 559-563. http://www.mdpi.com/2076-2615/2/4/559
Greek, R. and Hansen, L.A. (2012) The Development of Deep Brain Stimulation for Movement Disorders. Journal of Clinical Research & Bioethics, 3, 338-345. http://www.omicsonline.org/2155-9627/2155-9627-3-137.php?aid=9962 http://dx.doi.org/10.4172/2155-9627.1000137
Greek, R., Menache, A. and Rice, M.J. (2012) Animal Models in an Age of Personalized Medicine. Personalized Medicine, 9, 47-64. http://dx.doi.org/10.2217/pme.11.89
Greek, R., Pippus, A. and Hansen, L.A. (2012) The Nuremberg Code Subverts Human Health and Safety by Requiring Animal Modeling. BMC Medical Ethics, 13, 16. http://www.ncbi.nlm.nih.gov/pubmed/22769234 http://dx.doi.org/10.1186/1472-6939-13-16
Greek, R. and Rice, M.J. (2012) Animal Models and Conserved Processes. Theoretical Biology and Medical Modelling, 9, 40. http://www.tbiomed.com/content/9/1/40/abstract http://dx.doi.org/10.1186/1742-4682-9-40
Greek, R. (2013) Animal Models of Cancer in Light of Evolutionary Biology and Complexity Science. The Research and Biology of Cancer, Concept Press, Hong Kong.
Greek, R. (2013) Animal Models in Drug Development. In: Gowder, S., Ed., New Insights into Toxicity and Drug Testing, InTech, Manhattan, 124-152. http://dx.doi.org/10.5772/53893
Greek, R. and Hansen, L. (2013) The Strengths and Limits of Animal Models as Illustrated by the Discovery and Development of Antibacterials. Biological Systems: Open Access, 2, 109. http://omicsgroup.org/journals/the-strengths-and-limits-of-animal-models-as-illustrated-by- the-discovery-and-development-of-antibacterials-BSO.1000109.php?aid=14441
Greek, R. and Hansen, L.A. (2013) Questions Regarding the Predictive Value of One Evolved Complex Adaptive System for a Second: Exemplified by the SOD1 Mouse. Progress in Biophysics and Molecular Biology, 113, 231-253. http://www.sciencedirect.com/science/article/pii/S0079610713000539 http://dx.doi.org/10.1016/j.pbiomolbio.2013.06.002
Greek, R. and Menache, A. (2013) Systematic Reviews of Animal Models: Methodology versus Epistemology. International Journal of Medical Sciences, 10, 206-221. http://www.medsci.org/v10p0206.htm http://dx.doi.org/10.7150/ijms.5529
Jones, R.C. and Greek, R. (2013) A Review of the Institute of Medicine’s Analysis of Using Chimpanzees in Biomedical Research. Science and Engineering Ethics, 20, 481-504. http://www.ncbi.nlm.nih.gov/pubmed/23616243 http://dx.doi.org/10.1007/s11948-013-9442-7
Greek, R. and Shanks, N. (2009) FAQs about the Use of Animals in Science: A Handbook for the Scientifically Perplexed. University Press of America, Lanham.
Shanks, N. and Greek, R. (2009) Animal Models in Light of Evolution. Brown Walker, Boca Raton.
Schiller, J. (1967) Claude Bernard and Vivisection. Journal of the History of Medicine and Allied Sciences, 22, 246-260. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 4862494 http://dx.doi.org/10.1093/jhmas/XXII.3.246
Sechzer, J.A. (1983) The Ethical Dilemma of Some Classical Animal Experiments. Annals of the New York Academy of Sciences, 406, 5-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 6349466 http://dx.doi.org/10.1111/j.1749-6632.1983.tb53480.x
Anderson, B.O. and Harken, A.H. (1992) Carl John Wiggers’ Visionary Views on Vivisection. Annals of Surgery, 216, 80-86. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 1632706 http://dx.doi.org/10.1097/00000658-199207000-00012
Rupke, N. (1987) Vivisection in Historical Perspective. Routledge, London.
Mayer, J. (2008) The Expression of the Emotions in Man and Laboratory Animals. Victorian Studies, 50, 399-417. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 19244859 http://dx.doi.org/10.2979/VIC.2008.50.3.399
Bernard, C. (1957) An Introduction to the Study of Experimental Medicine. 1865. Dover, New York.
Darwin, C. (1936) The Descent of Man and Selection in Relation to Sex. Modern Library, New York.
LaFollette, H. and Shanks, N. (1994) Animal Experimentation: The Legacy of Claude Bernard. International Studies in the Philosophy of Science, 8, 195-210. http://dx.doi.org/10.1080/02698599408573495
Milner, R. (2009) Darwin’s Universe: Evolution from A to Z. University of California Press, Berkeley.
Osler, W. (1907) The Historical Development and Relative Value of Laboratory and Clinical Methods in Diagnosis. The Evolution of the Idea of Experiment in Medicine. Transactions of the Congress of American Physicians and Surgeons, 7, 1-8.
Greek, R. and Hicks, J. (2006) Debate on Animal Experimentation at the University of California-Irvine. http://www.afma-curedisease.org/images/GreekHICKS.pdf
Bailey, J., Thew, M. and Balls, M. (2013) An Analysis of the Use of Dogs in Predicting Human Toxicology and Drug Safety. ATLA, 41, 335-350.
Ahn, A.C., Tewari, M., Poon, C.S. and Phillips, R.S. (2006) The Limits of Reductionism in Medicine: Could Systems Biology Offer an Alternative? PLoS Medicine, 3, e208. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 16681415 http://dx.doi.org/10.1371/journal.pmed.0030208
Csete, M.E. and Doyle, J.C. (2002) Reverse Engineering of Biological Complexity. Science, 295, 1664-1669. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 11872830 http://dx.doi.org/10.1126/science.1069981
Goodwin, B. (2001) How the Leopard Changed Its Spots : The Evolution of Complexity. Princeton University Press, Princeton.
Jura, J., Wegrzyn, P. and Koj, A. (2006) Regulatory Mechanisms of Gene Expression: Complexity with Elements of Deterministic Chaos. Acta Biochimica Polonica, 53, 1-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 16505901
Kauffman, S.A. (1993) The Origins of Order: Self-Organization and Selection in Evolution. Oxford University Press, Oxford.
Kitano, H. (2002) Computational Systems Biology. Nature, 420, 206-210 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 12432404 http://dx.doi.org/10.1038/nature01254
Kitano, H. (2002) Systems Biology: A Brief Overview. Science, 295, 1662-1664. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 11872829 http://dx.doi.org/10.1126/science.1069492
Lewin, R. (1999) Complexity: Life at the Edge of Chaos. The University of Chicago Press, Chicago.
Morowitz, H.J. (2002) The Emergence of Everything: How the World Became Complex. Oxford University Press, Oxford.
Van Regenmortel, M. (2004) Reductionism and Complexity in Molecular Biology. Scientists Now Have the Tools to Unravel Biological Complexity and Overcome the Limitations of Reductionism. EMBO Reports, 5, 1016-1020. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 15520799
van Regenmortel, M. (2004) Biological Complexity Emerges from the Ashes of Genetic Reductionism. Journal of Molecular Recognition, 17, 145-148. http://dx.doi.org/10.1002/jmr.674
Van Regenmortel, M.H. and Hull, D.L. (2002) Promises and Limits of Reductionism in the Biomedical Sciences (Catalysts for Fine Chemical Synthesis). Wiley, West Sussex. http://dx.doi.org/10.1002/0470854189
Vicsek, T. (2002) The Bigger Picture. Nature, 418, 131. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 12110869 http://dx.doi.org/10.1038/418131a
Gell-Mann, M. (1994) The Quark and the Jaguar: Adventures in the Simple and Complex. Little, Brown and Company, Boston.
Spear, B.B., Heath-Chiozzi, M. and Huff, J. (2001) Clinical Application of Pharmacogenetics. Trends in Molecular Medicine, 7, 201-204. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 11325631 http://dx.doi.org/10.1016/S1471-4914(01)01986-4
Koren, G., Cairns, J., Chitayat, D., Gaedigk, A. and Leeder, S.J. (2006) Pharmacogenetics of Morphine Poisoning in a Breastfed Neonate of a Codeine-Prescribed Mother. Lancet, 368, 704. http://www.ncbi.nlm.nih.gov/pubmed/16920476 http://dx.doi.org/10.1016/S0140-6736(06)69255-6
Bhathena, A. and Spear, B.B. (2008) Pharmacogenetics: Improving Drug and Dose Selection. Current Opinion in Pharmacology, 8, 639-646. http://www.ncbi.nlm.nih.gov/pubmed/18762278 http://dx.doi.org/10.1016/j.coph.2008.07.013
Hughes, A.R., Spreen, W.R., Mosteller, M., Warren, L.L., Lai, E.H., Brothers, C.H., Cox, C., Nelsen, A.J., Hughes, S., Thorborn, D.E., Stancil, B., Hetherington, S.V., Burns, D.K. and Roses, A.D. (2008) Pharmacogenetics of Hypersensitivity to Abacavir: From PGx Hypothesis to Confirmation to Clinical Utility. Pharmacogenomics Journal, 8, 365-374. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 18332899 http://dx.doi.org/10.1038/tpj.2008.3
Blair, E. (2009) Predictive Tests and Personalised Medicine. Drug Discovery World, 27-31.
Bates, S. (2010) Progress towards Personalized Medicine. Drug Discovery Today, 15, 115-120. http://dx.doi.org/10.1016/j.drudis.2009.11.001
Dolgin, E. (2010) Big Pharma Moves from “Blockbusters” to “Niche Busters”. Nature Medicine, 16, 837.
Flaherty, K.T., Puzanov, I., Kim, K.B., Ribas, A., McArthur, G.A., Sosman, J.A., O’Dwyer, P.J., Lee, R.J., Grippo, J.F., Nolop, K. and Chapman, P.B. (2010) Inhibition of Mutated, Activated BRAF in Metastatic Melanoma. New England Journal of Medicine, 363, 809-819. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 20818844 http://dx.doi.org/10.1056/NEJMoa1002011
Froehlich, T.E., Epstein, J.N., Nick, T.G., Melguizo Castro, M.S., Stein, M.A., Brinkman, W.B., Graham, A.J., Langberg, J.M. and Kahn, R.S. (2011) Pharmacogenetic Predictors of Methylphenidate Dose-Response in Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 50, 1129-1139. http://linkinghub.elsevier.com/retrieve/pii/S0890856711006897?showall=true http://dx.doi.org/10.1016/j.jaac.2011.08.002
Hudson, K.L. (2011) Genomics, Health Care, and Society. New England Journal of Medicine, 365, 1033-1041. http://www.nejm.org/doi/full/10.1056/NEJMra1010517 http://dx.doi.org/10.1056/NEJMra1010517
Serrano, D., Lazzeroni, M., Zambon, C.F., Macis, D., Maisonneuve, P., Johansson, H., Guerrieri-Gonzaga, A., Plebani, M., Basso, D., Gjerde, J., Mellgren, G., Rotmensz, N., Decensi, A. and Bonanni, B. (2011) Efficacy of Tamoxifen Based on Cytochrome P450 2D6, CYP2C19 and SULT1A1 Genotype in the Italian Tamoxifen Prevention Trial. Pharmacogenomics Journal, 11, 100-107. http://dx.doi.org/10.1038/tpj.2010.17
Tan, I.B., Ivanova, T., Lim, K.H., Ong, C.W., Deng, N., Lee, J., Tan, S.H., Wu, J., Lee, M.H., Ooi, C.H., Rha, S.Y., Wong, W.K., Boussioutas, A., Yeoh, K.G., So, J., Yong, W.P., Tsuburaya, A., Grabsch, H., Toh, H.C., Rozen, S., Cheong, J.H., Noh, S.H., Wan, W.K., Ajani, J.A., Lee, J.Ä., Tellez, M.S. and Tan, P. (2011) Intrinsic Subtypes of Gastric Cancer, Based on Gene Expression Pattern, Predict Survival and Respond Differently to Chemotherapy. Gastroenterology, 141, 476-485. http://linkinghub.elsevier.com/retrieve/pii/S001650851100597X?showall=true http://dx.doi.org/10.1053/j.gastro.2011.04.042
Wang, D., Guo, Y., Wrighton, S.A., Cooke, G.E. and Sadee, W. (2011) Intronic Polymorphism in CYP3A4 Affects Hepatic Expression and Response to Statin Drugs. Pharmacogenomics Journal, 11, 274-286. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 20386561 http://dx.doi.org/10.1038/tpj.2010.28
Belmaker, R., Bersudsky, Y. and Agam, G. (2012) Individual Differences and Evidence-Based Psychopharmacology. BMC Medicine, 10, 110. http://www.ncbi.nlm.nih.gov/pubmed/23016518 http://dx.doi.org/10.1186/1741-7015-10-110
Powell, A.A., Talasaz, A.H., Zhang, H., Coram, M.A., Reddy, A., Deng, G., Telli, M.L., Advani, R.H., Carlson, R.W., Mollick, J.A., Sheth, S., Kurian, A.W., Ford, J.M., Stockdale, F.E., Quake, S.R., Pease, R.F., Mindrinos, M.N., Bhanot, G., Dairkee, S.H., Davis, R.W. and Jeffrey, S.S. (2012) Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines. PLoS ONE, 7, e33788. http://dx.doi.org/10.1371/journal.pone.0033788
Aldous, P. (2013) Your Genomic Future: Personalised Medicine Is Here. New Scientist. http://www.newscientist.com/article/mg21929333.100-your-genomic-future-personalised-medicine-is-here.html
Meyer, U.A. (1990) Genetic Polymorphisms of Drug Metabolism. Fundamental & Clinical Pharmacology, 4, 595-615. http://www.ncbi.nlm.nih.gov/pubmed/1982880 http://dx.doi.org/10.1111/j.1472-8206.1990.tb00041.x
Kalow, W. (1991) Interethnic Variation of Drug Metabolism. Trends in Pharmacological Sciences, 12, 102-107. http://www.ncbi.nlm.nih.gov/pubmed/2053186 http://dx.doi.org/10.1016/0165-6147(91)90516-U
Gonzalez, F.J. and Idle, J.R. (1994) Pharmacogenetic Phenotyping and Genotyping. Present Status and Future Potential. Clinical Pharmacokinetics, 26, 59-70. http://www.ncbi.nlm.nih.gov/pubmed/8137598 http://dx.doi.org/10.2165/00003088-199426010-00005
Nebert, D. (1997) Pharmacogenetics: 65 Candles on the Cake. Pharmacogenetics, 7, 435-440. http://dx.doi.org/10.1097/00008571-199712000-00001
Nebert, D.W., Ingelman-Sundberg, M. and Daly, A.K. (1999) Genetic Epidemiology of Environmental Toxicity and Cancer Susceptibility: Human Allelic Polymorphisms in Drug-Metabolizing Enzyme Genes, Their Functional Importance, and Nomenclature Issues. Drug Metabolism Reviews, 31, 467-487. http://www.ncbi.nlm.nih.gov/pubmed/10335448 http://dx.doi.org/10.1081/DMR-100101931
Karapetis, C.S., Khambata-Ford, S., Jonker, D.J., O’Callaghan, C.J., Tu, D., Tebbutt, N.C., Simes, R.J., Chalchal, H., Shapiro, J.D., Robitaille, S., Price, T.J., Shepherd, L., Au, H.J., Langer, C., Moore, M.J. and Zalcberg, J.R. (2008) K-Ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer. New England Journal of Medicine, 359, 1757-1765. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 18946061 http://dx.doi.org/10.1056/NEJMoa0804385
Pirmohamed, M. (2011) Pharmacogenetics: Past, Present and Future. Drug Discovery Today, 16, 852-861. http://dx.doi.org/10.1016/j.drudis.2011.08.006
Macdonald, J.S. (2002) Vive la Difference: Sex and Fluorouracil Toxicity. Journal of Clinical Oncology, 20, 1439-1441. http://www.ncbi.nlm.nih.gov/pubmed/11896088
Sloan, J.A., Goldberg, R.M., Sargent, D.J., Vargas-Chanes, D., Nair, S., Cha, S.S., Novotny, P.J., Poon, M.A., O’Connell, M.J. and Loprinzi, C.L. (2002) Women Experience Greater Toxicity with Fluorouracil-Based Chemotherapy for Colorectal Cancer. Journal of Clinical Oncology, 20, 1491-1498. http://www.ncbi.nlm.nih.gov/pubmed/11896096 http://dx.doi.org/10.1200/JCO.20.6.1491
Holden, C. (2005) Sex and the Suffering Brain. Science, 308, 1574. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 15947170 http://dx.doi.org/10.1126/science.308.5728.1574
Kaiser, J. (2005) Gender in the Pharmacy: Does It Matter? Science, 308, 1572. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 15947169 http://dx.doi.org/10.1126/science.308.5728.1572
Simon, V. (2005) Wanted: Women in Clinical Trials. Science, 308, 1517. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 15947140 http://dx.doi.org/10.1126/science.1115616
Couzin, J. (2007) Cancer Research. Probing the Roots of Race and Cancer. Science, 315, 592-594. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 17272699 http://dx.doi.org/10.1126/science.315.5812.592
Willyard, C. (2009) HIV Gender Clues Emerge. Nature Medicine, 15, 830. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 19661976 http://dx.doi.org/10.1038/nm0809-830b
Klein, S. and Huber, S. (2010) Sex Differences in Susceptibility to Viral Infection. In: Klein, S. and Roberts, C., Eds., Sex Hormones and Immunity to Infection, Springer-Verlag, Berlin, 93-122. http://dx.doi.org/10.1007/978-3-642-02155-8_4
Wald, C. and Wu, C. (2010) Of Mice and Women: The Bias in Animal Models. Science, 327, 1571-1572. http://dx.doi.org/10.1126/science.327.5973.1571
Canto, J.G., Rogers, W.J., Goldberg, R.J., Peterson, E.D., Wenger, N.K., Vaccarino, V., Kiefe, C.I., Frederick, P.D., Sopko, G. and Zheng, Z.-J. (2012) Association of Age and Sex with Myocardial Infarction Symptom Presentation and In-Hospital Mortality. JAMA: The Journal of the American Medical Association, 307, 813-822. http://jama.ama-assn.org/content/307/8/813.abstract http://dx.doi.org/10.1001/jama.2012.199
Favoni, R.E. and Alama, A. (2013) Preclinical Strategies Targeted at Non-Small-Cell Lung Cancer Signalling Pathways with Striking Translational Fallout. Drug Discovery Today, 18, 11-24. http://www.ncbi.nlm.nih.gov/pubmed/22885521 http://dx.doi.org/10.1016/j.drudis.2012.07.011
Lyons, M.R., Peterson, L.R., McGill, J.B., Herrero, P., Coggan, A.R., Saeed, I.M., Recklein, C., Schechtman, K.B. and Gropler, R.J. (2013) Impact of Sex on the Heart’s Metabolic and Functional Responses to Diabetic Therapies. American Journal of Physiology—Heart and Circulatory Physiology, 305, H1584-H1591. http://ajpheart.physiology.org/ajpheart/305/11/H1584.full.pdf http://ajpheart.physiology.org/content/305/11/H1584.long http://dx.doi.org/10.1152/ajpheart.00420.2013
Gregor, Z. and Joffe, L. (1978) Senile Macular Changes in the Black African. British Journal of Ophthalmology, 62, 547-550. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 687553 http://dx.doi.org/10.1136/bjo.62.8.547
Cheung, D.S., Warman, M.L. and Mulliken, J.B. (1997) Hemangioma in Twins. Annals of Plastic Surgery, 38, 269-274. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 9088466 http://dx.doi.org/10.1097/00000637-199703000-00014
Haiman, C.A., Stram, D.O., Wilkens, L.R., Pike, M.C., Kolonel, L.N., Henderson, B.E. and Le Marchand, L. (2006) Ethnic and Racial Differences in the Smoking-Related Risk of Lung Cancer. New England Journal of Medicine, 354, 333-342. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 16436765 http://dx.doi.org/10.1056/NEJMoa033250
Couzin, J. (2007) Human Genetics. In Asians and Whites, Gene Expression Varies by Race. Science, 315, 173-174. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 17218500 http://dx.doi.org/10.1126/science.315.5809.173a
Nature (2007) Research Highlights. Spot the Difference. Nature, 445, 129.
Spielman, R.S., Bastone, L.A., Burdick, J.T., Morley, M., Ewens, W.J. and Cheung, V.G. (2007) Common Genetic Variants Account for Differences in Gene Expression among Ethnic Groups. Nature Genetics, 39, 226-231. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 17206142 http://dx.doi.org/10.1038/ng1955
Stamer, U.M. and Stuber, F. (2007) The Pharmacogenetics of Analgesia. Expert Opinion on Pharmacotherapy, 8, 2235-2245. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 17927480 http://dx.doi.org/10.1517/14656566.8.14.2235
Kopp, J.B., Nelson, G.W., Sampath, K., Johnson, R.C., Genovese, G., An, P., Friedman, D., Briggs, W., Dart, R., Korbet, S., Mokrzycki, M.H., Kimmel, P.L., Limou, S., Ahuja, T.S., Berns, J.S., Fryc, J., Simon, E.E., Smith, M.C., Trachtman, H., Michel, D.M., Schelling, J.R., Vlahov, D., Pollak, M. and Winkler, C.A. (2011) APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy. Journal of the American Society of Nephrology, 22, 2129-2137. http://jasn.asnjournals.org/content/early/2011/10/06/ASN.2011040388.abstract http://dx.doi.org/10.1681/ASN.2011040388
Wilke, R.A. and Dolan, M.E. (2011) Genetics and Variable Drug Response. JAMA: The Journal of the American Medical Association, 306, 306-307. http://jama.ama-assn.org/content/306/3/306.short http://dx.doi.org/10.1001/jama.2011.998
Sarkar, M., Bacchetti, P., French, A.L., Tien, P., Glesby, M.J., Nowicki, M., Plankey, M., Gange, S., Sharp, G., Minkoff, H., Peters, M.G. and Women’s Interagency, H.I.V.S. (2012) Lower Liver-Related Death in African-American Women with Human Immunodeficiency Virus/Hepatitis C Virus Coinfection, Compared to Caucasian and Hispanic Women. Hepatology, 56, 1699-1705. http://www.ncbi.nlm.nih.gov/pubmed/22618868
Xu, H., Cheng, C., Devidas, M., Pei, D., Fan, Y., Yang, W., Neale, G., Scheet, P., Burchard, E.G., Torgerson, D.G., Eng, C., Dean, M., Antillon, F., Winick, N.J., Martin, P.L., Willman, C.L., Camitta, B.M., Reaman, G.H., Carroll, W.L., Loh, M., Evans, W.E., Pui, C.-H., Hunger, S.P., Relling, M.V. and Yang, J.J. (2012) ARID5B Genetic Polymorphisms Contribute to Racial Disparities in the Incidence and Treatment Outcome of Childhood Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. http://jco.ascopubs.org/content/early/2012/01/30/JCO.2011.38.0345.abstract
Dewland, T.A., Olgin, J.E., Vittinghoff, E. and Marcus, G.M. (2013) Incident Atrial Fibrillation among Asians, Hispanics, Blacks, and Whites. Circulation. http://circ.ahajournals.org/content/early/2013/09/27/CIRCULATIONAHA.113.002449
Pinto, J.M., Schumm, L.P., Wroblewski, K.E., Kern, D.W. and McClintock, M.K. (2013) Racial Disparities in Olfactory Loss among Older Adults in the United States. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. http://biomedgerontology.oxfordjournals.org/content/early/2013/05/19/gerona.glt063.abstract
Herndon, C.N. and Jennings, R.G. (1951) A Twin-Family Study of Susceptibility to Poliomyelitis. American Journal of Human Genetics, 3, 17-46. http://www.ncbi.nlm.nih.gov/pubmed/13171372
Alexanderson, B. and Borga, O. (1972) Interindividual Differences in Plasma Protein Binding of Nortriptyline in Man—A Twin Study. European Journal of Clinical Pharmacology, 4, 196-200. http://dx.doi.org/10.1007/BF00635795
Lin, T.M., Chen, C.J., Wu, M.M., Yang, C.S., Chen, J.S., Lin, C.C., Kwang, T.Y., Hsu, S.T., Lin, S.Y. and Hsu, L.C. (1989) Hepatitis B Virus Markers in Chinese Twins. Anticancer Research, 9, 737-741. http://www.ncbi.nlm.nih.gov/pubmed/2764519
Fraga, M.F., Ballestar, E., Paz, M.F., Ropero, S., Setien, F., Ballestar, M.L., Heine-Suner, D., Cigudosa, J.C., Urioste, M., Benitez, J., Boix-Chornet, M., Sanchez-Aguilera, A., Ling, C., Carlsson, E., Poulsen, P., Vaag, A., Stephan, Z., Spector, T.D., Wu, Y.Z., Plass, C. and Esteller, M. (2005) Epigenetic Differences Arise during the Lifetime of Monozygotic Twins. Proceedings of the National Academy of Sciences of the United States of America, 102, 10604-10609. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 16009939 http://dx.doi.org/10.1073/pnas.0500398102
Wong, A.H., Gottesman, I.I. and Petronis, A. (2005) Phenotypic Differences in Genetically Identical Organisms: The Epigenetic Perspective. Human Molecular Genetics, 14, R11-R18. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 15809262 http://dx.doi.org/10.1093/hmg/ddi116
Bruder, C.E., Piotrowski, A., Gijsbers, A.A., Andersson, R., Erickson, S., de Stahl, T.D., Menzel, U., Sandgren, J., von Tell, D., Poplawski, A., Crowley, M., Crasto, C., Partridge, E.C., Tiwari, H., Allison, D.B., Komorowski, J., van Ommen, G.J., Boomsma, D.I., Pedersen, N.L., den Dunnen, J.T., Wirdefeldt, K. and Dumanski, J.P. (2008) Phenotypically Concordant and Discordant Monozygotic Twins Display Different DNA Copy-Number-Variation Profiles. American Journal of Human Genetics, 82, 763-771. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 18304490 http://dx.doi.org/10.1016/j.ajhg.2007.12.011
Muqit, M.M., Larner, A.J., Sweeney, M.G., Sewry, C., Stinton, V.J., Davis, M.B., Healy, D.G., Payne, S.J., Chotai, K., Wood, N.W. and Lane, R.J. (2008) Multiple Mitochondrial DNA Deletions in Monozygotic Twins with OPMD. Journal of Neurology, Neurosurgery Psychiatry, 79, 68-71. http://dx.doi.org/10.1136/jnnp.2006.112250
Javierre, B.M., Fernandez, A.F., Richter, J., Al-Shahrour, F., Martin-Subero, J.I., Rodriguez-Ubreva, J., Berdasco, M., Fraga, M.F., O’Hanlon, T.P., Rider, L.G., Jacinto, F.V., Lopez-Longo, F.J., Dopazo, J., Forn, M., Peinado, M.A., Carreno, L., Sawalha, A.H., Harley, J.B., Siebert, R., Esteller, M., Miller, F.W. and Ballestar, E. (2010) Changes in the Pattern of DNA Methylation Associate with Twin Discordance in Systemic Lupus Erythematosus. Genome Research, 20, 170-179. http://genome.cshlp.org/content/20/2/170.abstract http://dx.doi.org/10.1101/gr.100289.109
Misch, E.A., Berrington, W.R., Vary Jr., J.C. and Hawn, T.R. (2010) Leprosy and the Human Genome. Microbiology and Molecular Biology Reviews: MMBR, 74, 589-620. http://www.ncbi.nlm.nih.gov/pubmed/21119019
Stankiewicz, P. and Lupski, J.R. (2010) Structural Variation in the Human Genome and Its Role in Disease. Annual Review of Medicine, 61, 437-455. http://dx.doi.org/10.1146/annurev-med-100708-204735
Bell, J.T. and Spector, T.D. (2011) A Twin Approach to Unraveling Epigenetics. Trends in Genetics: TIG, 27, 116-125. http://dx.doi.org/10.1016/j.tig.2010.12.005
Dempster, E.L., Pidsley, R., Schalkwyk, L.C., Owens, S., Georgiades, A., Kane, F., Kalidindi, S., Picchioni, M., Kravariti, E., Toulopoulou, T., Murray, R.M. and Mill, J. (2011) Disease-Associated Epigenetic Changes in Monozygotic Twins Discordant for Schizophrenia and Bipolar Disorder. Human Molecular Genetics, 20, 4786-4796. http://www.ncbi.nlm.nih.gov/pubmed/21908516 http://dx.doi.org/10.1093/hmg/ddr416
Gordon, L., Joo, J.H., Andronikos, R., Ollikainen, M., Wallace, E.M., Umstad, M.P., Permezel, M., Oshlack, A., Morley, R., Carlin, J.B., Saffery, R., Smyth, G.K. and Craig, J.M. (2011) Expression Discordance of Monozygotic Twins at Birth: Effect of Intrauterine Environment and a Possible Mechanism for Fetal Programming. Epigenetics, 6, 579-592. http://dx.doi.org/10.4161/epi.6.5.15072
Maiti, S., Kumar, K.H.B.G., Castellani, C.A., O’Reilly, R. and Singh, S.M. (2011) Ontogenetic de Novo Copy Number Variations (CNVs) as a Source of Genetic Individuality: Studies on Two Families with MZD Twins for Schizophrenia. PLoS ONE, 6, e17125. http://dx.doi.org/10.1371/journal.pone.0017125
Ollikainen, M. and Craig, J.M. (2011) Epigenetic Discordance at Imprinting Control Regions in Twins. Epigenomics, 3, 295-306. http://dx.doi.org/10.2217/epi.11.18
Chapman, S.J. and Hill, A.V.S. (2012) Human Genetic Susceptibility to Infectious Disease. Nature Reviews Genetics, 13, 175-188.
Czyz, W., Morahan, J., Ebers, G. and Ramagopalan, S. (2012) Genetic, Environmental and Stochastic Factors in Monozygotic Twin Discordance with a Focus on Epigenetic Differences. BMC Medicine, 10, 93. http://www.biomedcentral.com/1741-7015/10/93 http://dx.doi.org/10.1186/1741-7015-10-93
Halder, A., Jain, M., Chaudhary, I. and Varma, B. (2012) Chromosome 22q11.2 Microdeletion in Monozygotic Twins with Discordant Phenotype and Deletion Size. Molecular Cytogenetics, 5, 13. http://www.ncbi.nlm.nih.gov/pubmed/22413934 http://dx.doi.org/10.1186/1755-8166-5-13
Zhao, J., Goldberg, J., Bremner, J.D. and Vaccarino, V. (2012) Global DNA Methylation Is Associated with Insulin Resistance: A Monozygotic Twin Study. Diabetes, 61, 542-546. http://dx.doi.org/10.2337/db11-1048
Litchfield Jr., J.T. (1962) Symposium on Clinical Drug Evaluation and Human Pharmacology. XVI. Evaluation of the Safety of New Drugs by Means of Tests in Animals. Clinical Pharmacology Therapeutics, 3, 665-672. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14465857
Smith, R.L. and Caldwell, J. (1977) Drug Metabolism in Non-Human Primates. In: Parke, D.V. and Smith, R.L., Eds., Drug Metabolism—From Microbe to Man, Taylor & Francis, London, 331-356.
Fletcher, A.P. (1978) Drug Safety Tests and Subsequent Clinical Experience. Journal of the Royal Society of Medicine, 71, 693-696. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 712750
Ennever, F.K., Noonan, T.J. and Rosenkranz, H.S. (1987) The Predictivity of Animal Bioassays and Short-Term Genotoxicity Tests for Carcinogenicity and Non-Carcinogenicity to Humans. Mutagenesis, 2, 73-78. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 3331705 http://dx.doi.org/10.1093/mutage/2.2.73
Lumley, C. (1990) Clinical Toxicity: Could It Have Been Predicted? Premarketing Experience. In: Lumley, C. and Walker, S. Eds., Animal Toxicity Studies: Their Relevance for Man, Quay, London, 49-56.
Suter, K. (1990) What Can Be Learned from Case Studies? The Company Approach. In: Lumley, C. and Walker, S., Eds., Animal Toxicity Studies: Their Relevance for Man, Quay, Lancaster, 71-78.
Spriet-Pourra, C. and Auriche, M. (1994) SCRIP Reports. PJB Publications, New York.
Igarashi, T., Nakane, S. and Kitagawa, T. (1995) Predictability of Clinical Adverse Reactions of Drugs by General Pharmacology Studies. Journal of Toxicological Sciences, 20, 77-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 7473897 http://dx.doi.org/10.2131/jts.20.77
Igarashi, T., Yabe, T. and Noda, K. (1996) Study Design and Statistical Analysis of Toxicokinetics: A Report of JPMA Investigation of Case Studies. Journal of Toxicological Sciences, 21, 497-504. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 9035061 http://dx.doi.org/10.2131/jts.21.5_497
Chiou, W.L., Jeong, H.Y., Chung, S.M. and Wu, T.C. (2000) Evaluation of Using Dog as an Animal Model to Study the Fraction of Oral Dose Absorbed of 43 Drugs in Humans. Pharmaceutical Research, 17, 135-140. http://www.ncbi.nlm.nih.gov/pubmed/10751026 http://dx.doi.org/10.1023/A:1007552927404
Mahmood, I. (2000) Can Absolute Oral Bioavailability in Humans Be Predicted from Animals? A Comparison of Allometry and Different Indirect Methods. Drug Metabolism and Drug Interactions, 16, 143-155. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 10962646 http://dx.doi.org/10.1515/DMDI.2000.16.2.143
Johnson, J.I., Decker, S., Zaharevitz, D., Rubinstein, L.V., Venditti, J.M., Schepartz, S., Kalyandrug, S., Christian, M., Arbuck, S., Hollingshead, M. and Sausville, E.A. (2001) Relationships between Drug Activity in NCI Preclinical in Vitro and in Vivo Models and Early Clinical Trials. British Journal of Cancer, 84, 1424-1431. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 11355958 http://dx.doi.org/10.1054/bjoc.2001.1796
Grass, G.M. and Sinko, P.J. (2002) Physiologically-Based Pharmacokinetic Simulation Modelling. Advanced Drug Delivery Reviews, 54, 433-451. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 11922957 http://dx.doi.org/10.1016/S0169-409X(02)00013-3
Weaver, J.L., Staten, D., Swann, J., Armstrong, G., Bates, M. and Hastings, K.L. (2003) Detection of Systemic Hypersensitivity to Drugs Using Standard Guinea Pig Assays. Toxicology, 193, 203-217. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 14599760 http://dx.doi.org/10.1016/S0300-483X(03)00267-1
FDA (2004) Innovation or Stagnation? Challenge and Opportunity on the Critical Path to New Medical Products. http://www.fda.gov/downloads/ScienceResearch/SpecialTopics/CriticalPathInitiative/ CriticalPAthOpportunitiesReports/ucm113411.pdf
Kola, I. and Landis, J. (2004) Can the Pharmaceutical Industry Reduce Attrition Rates? Nature Reviews Drug Discovery, 3, 711-715. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 15286737 http://dx.doi.org/10.1038/nrd1470
Lesko, L.J. and Woodcock, J. (2004) Translation of Pharmacogenomics and Pharmacogenetics: A Regulatory Perspective. Nature Reviews Drug Discovery, 3, 763-769. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 15340386 http://dx.doi.org/10.1038/nrd1499
Shepard, T. and Lemire, R. (2004) Catalog of Teratogenic Agents. 11th Edition. Johns Hopkins, Baltimore.
Kummar, S., Kinders, R., Rubinstein, L., Parchment, R.E., Murgo, A.J., Collins, J., Pickeral, O., Low, J., Steinberg, S.M., Gutierrez, M., Yang, S., Helman, L., Wiltrout, R., Tomaszewski, J.E. and Doroshow, J.H. (2007) Compressing Drug Development Timelines in Oncology Using Phase “0” Trials. Nature Reviews. Cancer, 7, 131-139. http://www.ncbi.nlm.nih.gov/pubmed/17251919
Hughes, B. (2008) Industry Concern over EU Hepatotoxicity Guidance. Nature Reviews Drug Discovery, 7, 719-719. http://dx.doi.org/10.1038/nrd2677
Arrowsmith, J. (2011) Trial Watch: Phase III and Submission Failures: 2008-2010. Nature Reviews Drug Discovery, 10, 87-87. http://dx.doi.org/10.1038/nrd3375
Arrowsmith, J. (2011) Trial Watch: Phase II Failures: 2008-2010. Nature Reviews Drug Discovery, 10, 328-329. http://dx.doi.org/10.1038/nrd3439
Morgan, P., Graaf, P.H.V.D., Arrowsmith, J., Feltner, D.E., Drummond, K.S., Wegner, C.D. and Street, S.D.A. (2012) Can the Flow of Medicines Be Improved? Fundamental Pharmacokinetic and Pharmacological Principles toward Improving Phase II Survival. Drug Discovery Today, 17, 419-424. http://dx.doi.org/10.1016/j.drudis.2011.12.020
van Meer, P.J.K., Kooijman, M., Gispen-de Wied, C.C., Moors, E.H.M. and Schellekens, H. (2012) The Ability of Animal Studies to Detect Serious Post Marketing Adverse Events Is Limited. Regulatory Toxicology and Pharmacology, 64, 345-349. http://www.sciencedirect.com/science/article/pii/S027323001200181X http://dx.doi.org/10.1016/j.yrtph.2012.09.002
Seok, J., Warren, H.S., Cuenca, A.G., Mindrinos, M.N., Baker, H.V., Xu, W., Richards, D.R., McDonald-Smith, G.P., Gao, H., Hennessy, L., Finnerty, C.C., Lopez, C.M., Honari, S., Moore, E.E., Minei, J.P., Cuschieri, J., Bankey, P.E., Johnson, J.L., Sperry, J., Nathens, A.B., Billiar, T.R., West, M.A., Jeschke, M.G., Klein, M.B., Gamelli, R.L., Gibran, N.S., Brownstein, B.H., Miller-Graziano, C., Calvano, S.E., Mason, P.H., Cobb, J.P., Rahme, L.G., Lowry, S.F., Maier, R.V., Moldawer, L.L., Herndon, D.N., Davis, R.W., Xiao, W. and Tompkins, R.G. (2013) Genomic Responses in Mouse Models Poorly Mimic Human Inflammatory Diseases. Proceedings of the National Academy of Sciences of the United States of America, 110, 3507-3512. http://www.ncbi.nlm.nih.gov/pubmed/23401516 http://dx.doi.org/10.1073/pnas.1222878110
Buchbinder, S.P., Mehrotra, D.V., Duerr, A., Fitzgerald, D.W., Mogg, R., Li, D., Gilbert, P.B., Lama, J.R., Marmor, M., Del Rio, C., McElrath, M.J., Casimiro, D.R., Gottesdiener, K.M., Chodakewitz, J.A., Corey, L. and Robertson, M.N. (2008) Efficacy Assessment of a Cell-Mediated Immunity HIV-1 Vaccine (the Step Study): A Double-Blind, Randomised, Placebo-Controlled, Test-of-Concept Trial. Lancet, 372, 1881-1893. http://www.ncbi.nlm.nih.gov/pubmed/19012954 http://dx.doi.org/10.1016/S0140-6736(08)61591-3
Editorial (2007) Cold Shower for AIDS Vaccines. Nature Medicine, 13, 1389-1390. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 18064013
Gamble, L.J. and Matthews, Q.L. (2010) Current Progress in the Development of a Prophylactic Vaccine for HIV-1. Drug Design, Development and Therapy, 5, 9-26. http://www.ncbi.nlm.nih.gov/pubmed/21267356
Cheng, Y.D., Al-Khoury, L. and Zivin, J.A. (2004) Neuroprotection for Ischemic Stroke: Two Decades of Success and Failure. NeuroRx, 1, 36-45. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 15717006 http://dx.doi.org/10.1602/neurorx.1.1.36
Curry, S.H. (2003) Why Have So Many Drugs with Stellar Results in Laboratory Stroke Models Failed in Clinical Trials? A Theory Based on Allometric Relationships. Annals of the New York Academy of Sciences, 993, 69-74. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 12853296 http://dx.doi.org/10.1111/j.1749-6632.2003.tb07512.x
Faden, A.I. (2002) Neuroprotection and Traumatic Brain Injury: Theoretical Option or Realistic Proposition. Current Opinion in Neurology, 15, 707-712. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 12447109 http://dx.doi.org/10.1097/00019052-200212000-00008
Faden, A.I. and Stoica, B. (2007) Neuroprotection: Challenges and Opportunities. Archives of Neurology, 64, 794-800. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 17562927 http://dx.doi.org/10.1001/archneur.64.6.794
Feuerstein, G.Z. and Chavez, J. (2009) Translational Medicine for Stroke Drug Discovery: The Pharmaceutical Industry Perspective. Stroke, 40, S121-S125. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 19064772 http://dx.doi.org/10.1161/STROKEAHA.108.535104
Gilligan, A.K., Thrift, A.G., Sturm, J.W., Dewey, H.M., Macdonell, R.A. and Donnan, G.A. (2005) Stroke Units, Tissue Plasminogen Activator, Aspirin and Neuroprotection: Which Stroke Intervention Could Provide the Greatest Community Benefit? Cerebrovascular Diseases, 20, 239-244. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 16123543 http://dx.doi.org/10.1159/000087705
Ginsberg, M.D. (2008) Neuroprotection for Ischemic Stroke: Past, Present and Future. Neuropharmacology, 55, 363-389. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 18308347 http://dx.doi.org/10.1016/j.neuropharm.2007.12.007
Grotta, J. (2002) Neuroprotection Is Unlikely to Be Effective in Humans Using Current Trial Designs. Stroke, 33, 306-307. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 11779929
Macleod, M. (2004) Systematic Review and Meta-Analysis of Experimental Stroke. International Journal of Neuroprotection and Neuroregeneration, 1, 9-12.
O’Collins, V.E., Macleod, M.R., Cox, S.F., Van Raay, L., Aleksoska, E., Donnan, G.A. and Howells, D.W. (2011) Preclinical Drug Evaluation for Combination Therapy in Acute Stroke Using Systematic Review, Meta-Analysis, and Subsequent Experimental Testing. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 31, 962-975. http://www.ncbi.nlm.nih.gov/pubmed/20978519
Plum, F. (2001) Neuroprotection in Acute Ischemic Stroke. JAMA, 285, 1760-1761. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11277833 http://dx.doi.org/10.1001/jama.285.13.1760
Horstmann, D. (1985) The Poliomyelitis Story; a Scientific Hegira. Yale Journal of Biology and Medicine, 58, 79-90.
Oshinsky, D.M. (2005) Polio: An American Story. Oxford University Press.
Paul, J.R. (1971) A History of Poliomyelitis. Yale University Press, New Haven.
Smith, W.E., Miller, L., Elsasser, R.E. and Hubert, D.D. (1965) Tests for Carcinogenicity of Asbestos. Annals of the New York Academy of Sciences, 132, 456-488. http://www.ncbi.nlm.nih.gov/pubmed/5219568 http://dx.doi.org/10.1111/j.1749-6632.1965.tb41127.x
Royal Society of Medicine (1980) Successes, Failures and Hopes in Cancer Chemotherapy. Proceedings of an International Symposium by the Royal Society of Medicine, Medico-Pharmaceutical Forum, London.
Sitaram, N. and Gershon, S. (1983) From Animal Models to Clinical Testing—Promises and Pitfalls. Progress in Neuro-Psychopharmacology Biological Psychiatry, 7, 227-228. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6310692 http://dx.doi.org/10.1016/0278-5846(83)90112-4
Sietsema, W.K. (1989) The Absolute Oral Bioavailability of Selected Drugs. International Journal of Clinical Pharmacology, Therapy and Toxicology, 27, 179-211. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2654032
Eason, C.T., Bonner, F.W. and Parke, D.V. (1990) The Importance of Pharmacokinetic and Receptor Studies in Drug Safety Evaluation. Regulatory Toxicology and Pharmacology, 11, 288-307. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 2196638 http://dx.doi.org/10.1016/0273-2300(90)90028-A
Heywood, R. (1990) Clinical Toxicity—Could It Have Been Predicted? Post-Marketing Experience. In: Lumley, C.E. and Walker, S. Eds., Animal Toxicity Studies: Their Relevance for Man, Quay, Lancaster, 57-67.
Lin, J.H. (1995) Species Similarities and Differences in Pharmacokinetics. Drug Metabolism and Disposition, 23, 1008-1021. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 8654187
Connors, T. (1996) Anticancer Drug Development: The Way Forward. Oncologist, 1, 180-181. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 10387985
Gura, T. (1997) Cancer Models: Systems for Identifying New Drugs Are Often Faulty. Science, 278, 1041-1042. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 9381203 http://dx.doi.org/10.1126/science.278.5340.1041
Meijers, J.M., Swaen, G.M. and Bloemen, L.J. (1997) The Predictive Value of Animal Data in Human Cancer Risk Assessment. Regulatory Toxicology and Pharmacology, 25, 94-102. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 9185886 http://dx.doi.org/10.1006/rtph.1996.1080
Noble, M. (2000) Can Neural Stem Cells Be Used as Therapeutic Vehicles in the Treatment of Brain Tumors? Nature Medicine, 6, 369-370. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 10742131 http://dx.doi.org/10.1038/74610
van Zutphen, L.F. (2000) Is There a Need for Animal Models of Human Genetic Disorders in the Post-Genome Era? CompMed, 50, 10-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 10987660
Alving, C.R. (2002) Design and Selection of Vaccine Adjuvants: Animal Models and Human Trials. Vaccine, 20, S56-S64. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 12184368 http://dx.doi.org/10.1016/S0264-410X(02)00174-3
Barnes, J.C. and Hayes, A.G. (2002) CNS Drug Discovery: Realising the Dream. Drug Discovery World, 54-57.
Palfreyman, M.G., Charles, V. and Blander, J. (2002) The Importance of Using Human-Based Models in Gene and Drug Discovery. Drug Discovery World, 33-40.
Duyk, G. (2003) Attrition and Translation. Science, 302, 603-605. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 14576424 http://dx.doi.org/10.1126/science.1090521
Horrobin, D.F. (2003) Modern Biomedical Research: An Internally Self-Consistent Universe with Little Contact with Medical Reality? Nature Reviews Drug Discovery, 2, 151-154. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 12563306 http://dx.doi.org/10.1038/nrd1012
Höerig, H. and Pullman, W. (2004) From Bench to Clinic and Back: Perspective on the 1st IQPC Translational Research Conference. Journal of Translational Medicine, 2, 44. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 15610560 http://dx.doi.org/10.1186/1479-5876-2-44
Seligmann, B. (2004/5) Gene Expression as a Toxicological Screening Tool. The Use of Microarray Data in Drug Development and Requirements for FDA Audit and Approval. Drug Discovery World, 77-83.
Abbott, A. (2005) Animal Testing: More than a Cosmetic Change. Nature, 438, 144-146. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 16281001 http://dx.doi.org/10.1038/438144a
Butcher, E.C. (2005) Can Cell Systems Biology Rescue Drug Discovery? Nature Reviews Drug Discovery, 4, 461-467. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 15915152 http://dx.doi.org/10.1038/nrd1754
Chabner, B.A. and Roberts Jr., T.G. (2005) Timeline: Chemotherapy and the War on Cancer. Nature Reviews Cancer, 5, 65-72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 15630416 http://dx.doi.org/10.1038/nrc1529
Editorial (2005) The Time Is Now. Nature Reviews Drug Discovery, 4, 613. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 16106580
Kamb, A. (2005) What’s Wrong with Our Cancer Models? Nature Reviews Drug Discovery, 4, 161-165. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 15688078 http://dx.doi.org/10.1038/nrd1635
Littman, B.H. and Williams, S.A. (2005) The Ultimate Model Organism: Progress in Experimental Medicine. Nature Reviews Drug Discovery, 4, 631-638. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 16056389 http://dx.doi.org/10.1038/nrd1800
Abate-Shen, C. (2006) A New Generation of Mouse Models of Cancer for Translational Research. Clinical Cancer Research, 12, 5274-5276. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 17000659 http://dx.doi.org/10.1158/1078-0432.CCR-06-0500
Dennis, C. (2006) Cancer: Off by a Whisker. Nature, 442, 739-741. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 16915261 http://dx.doi.org/10.1038/442739a
FDA (2006) FDA Issues Advice to Make Earliest Stages of Clinical Drug Development More Efficient. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108576.htm
Hurko, O. (2006) Understanding the Strategic Importance of Biomarkers for the Discovery and Early Development Phases. Drug Discovery World, 63-74.
McGee, P. (2006) Breeding Better Animal Models. Drug Discovery & Development, 18-23.
O’Collins, V.E., Macleod, M.R., Donnan, G.A., Horky, L.L., van der Worp, B.H. and Howells, D.W. (2006) 1,026 Experimental Treatments in Acute Stroke. Annals of Neurology, 59, 467-477. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 16453316
Björquist, P., Sartipy, P., Strehl, R. and Hyllner, J. (2007) Human ES Cell Derived Functional Cells as Tools in Drug Discovery. Drug Discovery World, 17-24.
Dixit, R. and Boelsterli, U. (2007) Healthy Animals and Animal Models of Human Disease(s) in Safety Assessment of Human Pharmaceuticals, including Therapeutic Antibodies. Drug Discovery Today, 12, 336-342. http://dx.doi.org/10.1016/j.drudis.2007.02.018
Loisel, S., Ohresser, M., Pallardy, M., Dayde, D., Berthou, C., Cartron, G. and Watier, H. (2007) Relevance, Advantages and Limitations of Animal Models Used in the Development of Monoclonal Antibodies for Cancer Treatment. Critical Reviews in Oncology/Hematology, 62, 34-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 17197192 http://dx.doi.org/10.1016/j.critrevonc.2006.11.010
Alini, M., Eisenstein, S.M., Ito, K., Little, C., Kettler, A.A., Masuda, K., Melrose, J., Ralphs, J., Stokes, I. and Wilke, H.J. (2008) Are Animal Models Useful for Studying Human Disc Disorders/Degeneration? European Spine Journal, 17, 2-19. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 17632738 http://dx.doi.org/10.1007/s00586-007-0414-y
Bendtsen, F. and Moller, S. (2008) Pharmacological Effects Are Model Specific in Animal Models of Portal Hypertension. Hepatology International, 2, 397-398. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 19669314
Dragunow, M. (2008) The Adult Human Brain in Preclinical Drug Development. Nature Reviews Drug Discovery, 7, 659-666. http://dx.doi.org/10.1038/nrd2617
Matthews, R.A. (2008) Medical Progress Depends on Animal Models—Doesn’t It? Journal of the Royal Society of Medicine, 101, 95-98. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 18299631 http://dx.doi.org/10.1258/jrsm.2007.070164
Wall, R.J. and Shani, M. (2008) Are Animal Models as Good as We Think? Theriogenology, 69, 2-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 17988725 http://dx.doi.org/10.1016/j.theriogenology.2007.09.030
Young, M. (2008) Prediction v Attrition. Drug Discovery World, 9-12.
Enna, S.J. and Williams, M. (2009) Defining the Role of Pharmacology in the Emerging World of Translational Research. Advances in Pharmacology, 57, 1-30. http://www.ncbi.nlm.nih.gov/pubmed/20230758 http://dx.doi.org/10.1016/S1054-3589(08)57001-3
Geerts, H. (2009) Of Mice and Men: Bridging the Translational Disconnect in CNS Drug Discovery. CNS Drugs, 23, 915-926. http://www.ncbi.nlm.nih.gov/pubmed/19845413 http://dx.doi.org/10.2165/11310890-000000000-00000
Markou, A., Chiamulera, C., Geyer, M.A., Tricklebank, M. and Steckler, T. (2009) Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 34, 74-89. http://www.ncbi.nlm.nih.gov/pubmed/18830240
Regenberg, A., Mathews, D.J., Blass, D.M., Bok, H., Coyle, J.T., Duggan, P., Faden, R., Finkel, J., Gearhart, J.D., Hillis, A., Hoke, A., Johnson, R., Johnston, M., Kahn, J., Kerr, D., King, P., Kurtzberg, J., Liao, S.M., McDonald, J.W., McKhann, G., Nelson, K.B., Rao, M., Siegel, A.W., Smith, K., Solter, D., Song, H., Sugarman, J., Vescovi, A., Young, W., Greely, H.T. and Traystman, R.J. (2009) The Role of Animal Models in Evaluating Reasonable Safety and Efficacy for Human Trials of Cell-Based Interventions for Neurologic Conditions. Journal of Cerebral Blood Flow Metabolism, 29, 1-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 18728679 http://dx.doi.org/10.1038/jcbfm.2008.98
Taylor, D.L. (2009) Human vs Rodent. Drug Discovery & Development, 12, 16-18.
Brennan, R., Federico, S. and Dyer, M.A. (2010) The War on Cancer: Have We Won the Battle but Lost the War? Oncotarget, 1, 77-83. http://www.ncbi.nlm.nih.gov/pubmed/20877440
Editorial (2010) Learning from Failure. Nature Reviews Drug Discovery, 9, 499-499.
Hait, W.N. (2010) Anticancer Drug Development: The Grand Challenges. Nature Reviews Drug Discovery, 9, 253-254. http://dx.doi.org/10.1038/nrd3144
Hampel, H., Frank, R., Broich, K., Teipel, S.J., Katz, R.G., Hardy, J., Herholz, K., Bokde, A.L.W., Jessen, F., Hoessler, Y.C., Sanhai, W.R., Zetterberg, H., Woodcock, J. and Blennow, K. (2010) Biomarkers for Alzheimer’s Disease: Academic, Industry and Regulatory Perspectives. Nature Reviews Drug Discovery, 9, 560-574. http://www.nature.com/nrd/journal/v9/n7/suppinfo/nrd3115_S1.html http://dx.doi.org/10.1038/nrd3115
M.E. (2010) In This Issue. Models That Better Mimic Human Cancer. Nature Biotechnology, 28, vii.
Paul, S.M., Mytelka, D.S., Dunwiddie, C.T., Persinger, C.C., Munos, B.H., Lindborg, S.R. and Schacht, A.L. (2010) How to Improve R&D Productivity: The Pharmaceutical Industry’s Grand Challenge. Nature Reviews Drug Discovery, 9, 203-214. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 20168317
Zhang, Q., Bhattacharya, S., Andersen, M.E. and Conolly, R.B. (2010) Computational Systems Biology and Dose-Response Modeling in Relation to New Directions in Toxicity Testing. Journal of Toxicology and Environmental Health. Part B, Critical Reviews, 13, 253-276. http://www.ncbi.nlm.nih.gov/pubmed/20574901 http://dx.doi.org/10.1080/10937404.2010.483943
Zielinska, E. (2010) Building a Better Mouse. The Scientist, 24, 34-38.
Chapman, A.R. (2011) Addressing the Ethical Challenges of First-in-Human Trials. Journal of Clinical Research Bioethics, 2, 113. http://dx.doi.org/10.4172/2155-9627.1000113
Collins, F.S. (2011) Reengineering Translational Science: The Time Is Right. Science Translational Medicine, 3, Article ID: 90cm17. http://stm.sciencemag.org/content/3/90/90cm17.abstract http://dx.doi.org/10.1126/scitranslmed.3002747
Elferink, M.G.L., Olinga, P., van Leeuwen, E.M., Bauerschmidt, S., Polman, J., Schoonen, W.G., Heisterkamp, S.H. and Groothuis, G.M.M. (2011) Gene Expression Analysis of Precision-Cut Human Liver Slices Indicate Stable Expression of ADME-Tox Related Genes. Toxicology and Applied Pharmacology, Accepted Manuscript. http://www.sciencedirect.com/science/article/B6WXH-52F85M5-2/2/44cac7a89411ba3c6851509d7fe01233
Engber, D. (2011) Lab Mice: Are They Limiting Our Understanding of Human Disease? http://www.slate.com/articles/health_and_science/the_mouse_trap/2011/11/lab_mice_are_they_ limiting_our_understanding_of_human_disease_.single.html
Force, T. and Kolaja, K.L. (2011) Cardiotoxicity of Kinase Inhibitors: The Prediction and Translation of Preclinical Models to Clinical Outcomes. Nature Reviews Drug Discovery, 10, 111-126. http://dx.doi.org/10.1038/nrd3252
Giri, S. and Bader, A. (2011) Foundation Review: Improved Preclinical Safety Assessment Using Micro-BAL Devices: The Potential Impact on Human Discovery and Drug Attrition. Drug Discovery Today, 16, 382-397. http://dx.doi.org/10.1016/j.drudis.2011.02.012
Holmes, A.M., Solari, R. and Holgate, S.T. (2011) Animal Models of Asthma: Value, Limitations and Opportunities for Alternative Approaches. Drug Discovery Today, 16, 659-670. http://dx.doi.org/10.1016/j.drudis.2011.05.014
Kay, M.A. (2011) State-of-the-Art Gene-Based Therapies: The Road Ahead. Nature Reviews Genetics, 12, 316-328. http://dx.doi.org/10.1038/nrg2971
Lutz, D. (2011) New Study Calls into Question Reliance on Animal Models in Cardiovascular Research. http://news.wustl.edu/news/Pages/22540.aspx
McArthur, R. (2011) Editorial: Many Are Called Yet Few Are Chosen. Are Neuropsychiatric Clinical Trials Letting Us Down? Drug Discovery Today, 16, 173-175. http://dx.doi.org/10.1016/j.drudis.2010.12.005
Mullard, A. (2011) Marc Kirschner. Nature Reviews Drug Discovery, 10, 894-894. http://dx.doi.org/10.1038/nrd3613
News & Analysis (2011) News in Brief. Nature Reviews Drug Discovery, 10, 889-889. http://dx.doi.org/10.1038/nrd3609
Reuters (2011) U.S. to Develop Chip That Tests If a Drug Is Toxic. http://www.msnbc.msn.com/id/44554007/ns/health-health_care/
Sharp, P.A. and Langer, R. (2011) Promoting Convergence in Biomedical Science. Science, 333, 527. http://www.sciencemag.org/content/333/6042/527.short http://dx.doi.org/10.1126/science.1205008
Cook, N., Jodrell, D.I. and Tuveson, D.A. (2012) Predictive in Vivo Animal Models and Translation to Clinical Trials. Drug Discovery Today, 17, 253-260. http://dx.doi.org/10.1016/j.drudis.2012.02.003
Drake III, D.R., Singh, I., Nguyen, M.N., Kachurin, A., Wittman, V., Parkhill, R., Kachurina, O., Moser, J.M., Burdin, N., Moreau, M., Mistretta, N., Byers, A.M., Dhir, V., Tapia, T.M., Vernhes, C., Gangur, J., Kamala, T., Swaminathan, N. and Warren, W.L. (2012) In Vitro Biomimetic Model of the Human Immune System for Predictive Vaccine Assessments. Disruptive Science and Technology, 1, 28-40. http://dx.doi.org/10.1089/dst.2012.0006
Herper, M. (2012) Can Bush’s NIH Chief Fix the Drug Industry? http://www.forbes.com/sites/matthewherper/2012/06/06/can-bushs-nih-chief-fix-the-drug-industry/2/
Khanna, I. (2012) Drug Discovery in Pharmaceutical Industry: Productivity Challenges and Trends. Drug Discovery Today, 17, 1088-1102. http://www.ncbi.nlm.nih.gov/pubmed/22627006 http://dx.doi.org/10.1016/j.drudis.2012.05.007
Ledford, H. (2012) Success through Cooperation.
Marusina, K. (2012) Animal Models Get Closer to Mimicking Humans. http://www.genengnews.com/gen-articles/animal-models-get-closer-to-mimicking-humans/4529/?page=1
Millan, M.J., Agid, Y., Brune, M., Bullmore, E.T., Carter, C.S., Clayton, N.S., Connor, R., Davis, S., Deakin, B., Derubeis, R.J., Dubois, B., Geyer, M.A., Goodwin, G.M., Gorwood, P., Jay, T.M., Joels, M., Mansuy, I.M., Meyer-Lindenberg, A., Murphy, D., Rolls, E., Saletu, B., Spedding, M., Sweeney, J., Whittington, M. and Young, L.J. (2012) Cognitive Dysfunction in Psychiatric Disorders: Characteristics, Causes and the Quest for Improved Therapy. Nature Reviews. Drug Discovery, 11, 141-168. http://www.ncbi.nlm.nih.gov/pubmed/22293568
Mullane, K. and Williams, M. (2012) Translational Semantics and Infrastructure: Another Search for the Emperor’s New Clothes? Drug Discovery Today, 17, 459-468. http://www.ncbi.nlm.nih.gov/pubmed/22269133 http://dx.doi.org/10.1016/j.drudis.2012.01.004
Neuzil, P., Giselbrecht, S., Lange, K., Huang, T.J. and Manz, A. (2012) Revisiting Lab-on-a-Chip Technology for Drug Discovery. Nature Reviews. Drug Discovery, 11, 620-632. http://www.ncbi.nlm.nih.gov/pubmed/22850786 http://dx.doi.org/10.1038/nrd3799
Opar, A. (2012) Overtaking the DILI Model-T. Nature Reviews Drug Discovery, 11, 585-586. http://dx.doi.org/10.1038/nrd3818
Prater, D.A. (2012) Development and Use of Advanced Testing Approaches by the U.S. FDA. http://www.hsi.org/issues/advancing_science/facts/ep-workshop-oct-2012/prater.pdf
Raven, K. (2012) Rodent Models of Sepsis Found Shockingly Lacking. Nature Medicine, 18, 998-998. http://dx.doi.org/10.1038/nm0712-998a
Rice, J. (2012) Animal Models: Not Close Enough. Nature, 484, S9. http://dx.doi.org/10.1038/nature11102
Shaffer, C. (2012) Safety through Sequencing. http://www.dddmag.com/article-Safety-Through-Sequencing-12412.aspx?et_cid=2450547&et_rid= 45518461&linkid=http%3a%2f%2fwww.dddmag.com%2farticle-Safety-Through-Sequencing-12412.aspx
Taneja, A., Di Iorio, V.L., Danhof, M. and Della Pasqua, O. (2012) Translation of Drug Effects from Experimental Models of Neuropathic Pain and Analgesia to Humans. Drug Discovery Today, 17, 837-849. http://www.ncbi.nlm.nih.gov/pubmed/22445930 http://dx.doi.org/10.1016/j.drudis.2012.02.010
Uhl, E.W., Whitley, E., Galbreath, E., McArthur, M. and Oglesbee, M.J. (2012) Evolutionary Aspects of Animal Models. Veterinary Pathology, 49, 876-878. http://www.ncbi.nlm.nih.gov/pubmed/22983990 http://dx.doi.org/10.1177/0300985812456214
Fernandes, P. and Vali, S. (2012) Predicting Pathway Effects. http://www.dddmag.com/articles/2012/06/predicting-pathway-effects?et_cid=2695933&et_rid= 45518461&linkid=http%3a%2f%2fwww.dddmag.com%2farticles%2f2012%2f06%2fpredicting-pathway- effects
Sarter, M. and Tricklebank, M. (2012) Revitalizing Psychiatric drug Discovery. Nature Reviews Drug Discovery, 11, 423-424. http://dx.doi.org/10.1038/nrd3755
Griebel, G. and Holsboer, F. (2012) Neuropeptide Receptor Ligands as Drugs for Psychiatric Diseases: The End of the Beginning? Nature Reviews Drug Discovery, 11, 462-478. http://dx.doi.org/10.1038/nrd3702
Tallman, J.F. (1999) Neuropsychopharmacology at the New Millennium: New Industry Directions. Neuropsychopharmacology, 20, 99-105.
Davis, M.M. (2008) A Prescription for Human Immunology. Immunity, 29, 835-838. http://dx.doi.org/10.1016/j.immuni.2008.12.003
MacDonald, J.S. and Robertson, R.T. (2009) Toxicity Testing in the 21st Century: A View from the Pharmaceutical Industry. Toxicological Sciences: An Official Journal of the Society of Toxicology, 110, 40-46. http://dx.doi.org/10.1093/toxsci/kfp088
FDA (2011) Advancing Regulatory Science at FDA: A Strategic Plan. http://www.fda.gov/ScienceResearch/SpecialTopics/RegulatoryScience/ucm267719.htm
Community Corner (2012) A Step Closer to Effective Transplant Tolerance? Nature Medicine, 18, 664-665. http://dx.doi.org/10.1038/nm.2770
McManus, R. (2013) Ex-Director Zerhouni Surveys Value of NIH Research. http://nihrecord.od.nih.gov/newsletters/2013/06_21_2013/story1.htm
Scannell, J.W., Blanckley, A., Boldon, H. and Warrington, B. (2012) Diagnosing the Decline in Pharmaceutical R&D Efficiency. Nature Reviews Drug Discovery, 11, 191-200. http://dx.doi.org/10.1038/nrd3681
Suggitt, M. and Bibby, M.C. (2005) 50 Years of Preclinical Anticancer Drug Screening: Empirical to Target-Driven Approaches. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 11, 971-981.
Committee on Revising Science and Creationism (2008) Science, Evolution, and Creationism. National Academy of Sciences, Washington DC.
American Association for the Advancement of Science (2011) Q & A on Evolution and Intelligent Design. http://www.aaas.org/news/press_room/evolution/qanda.shtml
Popper, K. (2002) Conjectures and Refutations: The Growth of Scientific Knowledge. 2nd Edition, Routledge Classics, Routledge, New York.
Patz, J.A., McGeehin, M.A., Bernard, S.M., Ebi, K.L., Epstein, P.R., Grambsch, A., Gubler, D.J., Reither, P., Romieu, I., Rose, J.B., Samet, J.M. and Trtanj, J. (2000) The Potential Health Impacts of Climate Variability and Change for the United States: Executive Summary of the Report of the Health Sector of the U.S. National Assessment. Environmental Health Perspectives, 108, 367-376. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1638004/ http://dx.doi.org/10.1289/ehp.00108367
Feenstra, J.F., Burton, I., Smith, J.B. and Tol, R.S.J. (1998) Handbook on Methods for Climate Change Impact Assessment and Adaptation Strategies. http://lib.icimod.org/record/13767/files/7157.pdf
Barber, B. (1961) Resistance by Scientists to Scientific Discovery. Science, 134, 596-602. http://www.ncbi.nlm.nih.gov/pubmed/13686762 http://dx.doi.org/10.1126/science.134.3479.596
Gad, S. (2007) Preface. In: Gad, S., Ed., Animal Models in Toxicology, CRC Press, Boca Raton, 1-18.
Campbell, D. (2012) Public Opposition to Animal Testing Grows. http://www.theguardian.com/science/2012/oct/19/public-opposition-animal-testing
Hart, B.A., Abbott, D.H., Nakamura, K. and Fuchs, E. (2012) The Marmoset Monkey: A Multi-Purpose Preclinical and Translational Model of Human Biology and Disease. Drug Discovery Today, 17, 1160-1165. http://www.ncbi.nlm.nih.gov/pubmed/22728226 http://dx.doi.org/10.1016/j.drudis.2012.06.009
Gibson, E. (2012) Q&A: Dr. Keith Cheng, Researcher at Penn State’s College of Medicine, Shares Views on Using Animals in Scientific Research. http://www.pennlive.com/midstate/index.ssf/2012/04/qa_dr_keith_cheng_researcher_a.html
Vassar, R. (2011) Alzheimer’s Therapy: A BACE in the Hand? Nature Medicine, 17, 932-933. http://dx.doi.org/10.1038/nm0811-932
Thorstensson, R. (2006) Medicinska försök på apor är inget etiskt problem för mig (Medical research on apes is no ethical problem for me). Infectious Diseases, Kronikor. http://www.smittskyddsinstitutet.se/smittskydd/arkiv/kronikor/medicinska-forsok-pa-apor-ar-inget-etiskt- problem-formig/
Rudczynski, A.B. (2011) Letter. New Haven Register, New Haven.
Hau, J. (2003) Animal Models. In: Hau, J. and van Hoosier Jr., G.K., Eds., Handbook of Laboratory Animal Science, 2nd Edition, Animal Models, CRC Press, Boca Raton, 1-9.
Committee on Applications of Toxicogenomic Technologies to Predictive Toxicology and Risk Assessment, N.R.C. (2007) Applications of Toxicogenomic Technologies to Predictive Toxicology and Risk Assessment. National Academy of Sciences, Washington DC.
Editors (2011) In This Issue. Nature Reviews Drug Discovery, 10, 239. http://dx.doi.org/10.1038/nrd3411
Mankoff, S.P., Brander, C., Ferrone, S. and Marincola, F.M. (2004) Lost in Translation: Obstacles to Translational Medicine. Journal of Translational Medicine, 2, 14. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 15149545 http://dx.doi.org/10.1186/1479-5876-2-14
Schreiber, S.L., Shamji, A.F., Clemons, P.A., Hon, C., Koehler, A.N., Munoz, B., Palmer, M., Stern, A.M., Wagner, B.K., Powers, S., Lowe, S.W., Guo, X., Krasnitz, A., Sawey, E.T., Sordella, R., Stein, L., Trotman, L.C., Califano, A., Dalla-Favera, R., Ferrando, A., Iavarone, A., Pasqualucci, L., Silva, J., Stockwell, B.R., Hahn, W.C., Chin, L., DePinho, R.A., Boehm, J.S., Gopal, S., Huang, A., Root, D.E., Weir, B.A., Gerhard, D.S., Zenklusen, J.C., Roth, M.G., White, M.A., Minna, J.D., MacMillan, J.B. and Posner, B.A. (2010) Towards Patient-Based Cancer Therapeutics. Nature Biotechnology, 28, 904-906. http://dx.doi.org/10.1038/nbt0910-904
Riveros, C., Dechartres, A., Perrodeau, E., Haneef, R., Boutron, I. and Ravaud, P. (2013) Timing and Completeness of Trial Results Posted at ClinicalTrials.gov and Published in Journals. PLoS Medicine, 10, Article ID: e1001566. http://www.plosmedicine.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pmed. 1001566&representation=PDF http://dx.doi.org/10.1371/journal.pmed.1001566
McBride, W. (1961) Letter. Thalidomide and Congential Abnormalities. Lancet, 278, 1358.
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., Dorato, M., Van Deun, K., Smith, P., Berger, B. and Heller, A. (2000) Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals. Regulatory Toxicology and Pharmacology, 32, 56-67. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 11029269 http://dx.doi.org/10.1006/rtph.2000.1399
Oesterhelweg, L., Krober, S., Rottmann, K., Willhoft, J., Braun, C., Thies, N., Puschel, K., Silkenath, J. and Gehl, A. (2008) Cadaver Dogs—A Study on Detection of Contaminated Carpet Squares. Forensic Science International, 174, 35-39. http://dx.doi.org/10.1016/j.forsciint.2007.02.031
Davis, H. (1988) The Accuracy of Industry Data from Death Certificates for Workplace Homicide Victims. American Journal of Public Health, 78, 1579-1581. http://www.ncbi.nlm.nih.gov/pubmed/3189637 http://dx.doi.org/10.2105/AJPH.78.12.1579
Buchanich, J.M., Youk, A.O., Marsh, G.M., Kennedy, K.J., Esmen, N.A., Lacey, S.E., Hancock, R., Cunningham, M.A., Lieberman, F.S. and Fleissner, M.L. (2010) Long-Term Health Experience of Jet Engine Manufacturing Workers: IV. A Comparison of Central Nervous System Cancer Ascertainment Using Mortality and Incidence Data. Annals of Epidemiology, 20, 759-765. http://www.ncbi.nlm.nih.gov/pubmed/20816315 http://dx.doi.org/10.1016/j.annepidem.2010.06.008
Cocco, P. (2012) Advances in the Retrospective Assessment of Occupational Exposures: Results from the European Case-Control Study EPILYMPH. http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=21&ved=0CMABEBYwFA&url=http%3A%2F%2Fwww.bohs. org%2FWorkArea%2Flinkit.aspx%3FLinkIdentifier%3Did%26ItemID%3D2117%26libID%3D2134&ei=eh KYUrW0IM77oASL94DQBQ&usg=AFQjCNGX-VbKrn9JPlVVHSjS8ksJhaB6Vw&sig2=rW2RAy_R5D6ezOQ7J0DGnA
Holloway, M. and Nwaoha, C. (2012) Dictionary of Industrial Terms. Wiley, John & Sons, Incorporated, London.
Roy, S., Sajeev, A.S.M., Bihary, S. and Ranjan, A. (2011) An Empirical Study of Error Patterns in Industrial Business Process Models. IEEE Transactions on Services Computing. http://www.computer.org/csdl/trans/sc/preprint/06464253-abs.html
Karwowski, W. (2001) The Strain Index. In: Karwowski, W., Ed., International Encyclopedia of Ergonomics and Human Factors, CRC Press, Boca Rotan, 1600.
Dhandayudam, P. and Krishnamurthi, I. (2013) Customer Behavior Analysis Using Rough Set Approach. Journal of Theoretical and Applied Electronic Commerce Research, 18. http://www.scielo.cl/scielo.php?pid=S0718-18762013000200003&script=sci_arttext
Clary, C. and Kestens, Y. (2013) Field Validation of Secondary Data Sources: A Novel Measure of Representativity Applied to a Canadian Food Outlet Database. International Journal of Behavioral Nutrition and Physical Activity, 10, 77. http://www.ijbnpa.org/content/10/1/77 http://dx.doi.org/10.1186/1479-5868-10-77
Weiss, S.M., Galen, R.S. and Tadepalli, P.V. (1988) Maximizing the Predictive Value of Production Rules. http://www.dtic.mil/dtic/tr/fulltext/u2/a200309.pdf
Uren, P., Cameron-Jones, R. and Sale, A. (2008) Improving Promoter Prediction Using Mulitple Instance Learning. In: Wobcke, W. and Zhang, M., Eds., AI 2008: Advances in Artificial Intelligence: 21st Australasian Joint Conference on Artificial Intelligence, Auckland, 3-5 December 2008, 289-299.
Mortara (2013) Vision Premier Holter Software. http://www.mortara.com/products/healthcare/physician-offices/holter-monitoring/ vision-premier-holter-software/
Barnes, D. (2013) Industry Perspective: Big Data and Big Data Analytics. http://www.eiseverywhere.com/file_uploads/dbece17417f38de495ce73d330adf4bc_MON_ 1015am_Big_Data_Track_TUTORIAL_David_Barnes.pdf
Snyder, J. (2011) Comparing Industry-Leading Anti-Spam Services Results from 12 Months of Testing. http://www.opus1.com/www/whitepapers/antispamresults2010.pdf
Sullivan, J.M., Tsimhoni, O. and Bogard, S. (2007) Warning Reliability and Driver Performance in Naturalistic Driving. http://deepblue.lib.umich.edu/bitstream/handle/2027.42/58732/100248.pdf?sequence=1
Que, J., Tsui, F.-C. and Espino, J. (2008) A Z-Score Based Multi-Level Spatial Clustering Algorithm for the Detection of Disease Outbreaks. In: Zeng, D., Chen, H., Rolka, H. and Lober, W.B., Eds., Biosurveillance and Biosecurity: International, 108-118.
Almeida, J.D.S., Silva, A.C. and Paiva, A.C. (2011) Automatic Eye Detection in Human Faces Using Geostatistical Functions and Support Vector Machines. In: Kamel, M. and Campilho, A., Eds., Image Analysis and Recognition: 8th International Conference, ICIAR 2011, Burnaby, 22-24 June 2011, 151-160.
Jekel, J.F., Katz, D.L., Wild, D. and Elmore, J.G. (2007) Epidemiology, Biostatistics and Preventive Medicine: With Student Consult Online Access, 3rd Edition, Saunders.
Grimes, D.A. and Schulz, K.F. (2005) Refining Clinical Diagnosis with Likelihood Ratios. The Lancet, 365, 1500-1505. http://linkinghub.elsevier.com/retrieve/pii/S0140673605664227 http://dx.doi.org/10.1016/S0140-6736(05)66422-7
Business Dictionary (2013) Evidential Value. http://www.businessdictionary.com/definition/evidential-value.html
The Law Dictionary (2013) Evidential Value. http://thelawdictionary.org/evidential-value/
Xu, H., Yang, W., Perez-Andreu, V., Devidas, M., Fan, Y., Cheng, C., Pei, D., Scheet, P., Burchard, E.G.l., Eng, C., Huntsman, S., Torgerson, D.G., Dean, M., Winick, N.J., Martin, P.L., Camitta, B.M., Bowman, W.P., Willman, C.L., Carroll, W.L., Mullighan, C.G., Bhojwani, D., Hunger, S.P., Pui, C.-H., Evans, W.E., Relling, M.V., Loh, M.L. and Yang, J.J. (2013) Novel Susceptibility Variants at 10p12.31-12.2 for Childhood Acute Lymphoblastic Leukemia in Ethnically Diverse Populations. Journal of the National Cancer Institute. http://jnci.oxfordjournals.org/content/early/2013/03/08/jnci.djt042.abstract
Sarkar, M., Bacchetti, P., French, A.L., Tien, P., Glesby, M.J., Nowicki, M., Plankey, M., Gange, S., Sharp, G., Minkoff, H. and Peters, M.G. (2012) Lower Liver-Related Death in African-American Women with Human Immunodeficiency Virus/Hepatitis C Virus Coinfection, Compared to Caucasian and Hispanic Women. Hepatology, 56, 1699-1705. http://www.ncbi.nlm.nih.gov/pubmed/22618868 http://dx.doi.org/10.1002/hep.25859
Abou-Donia, M.B., Lapadula, D.M. and Carrington, C.D. (1988) Biochemical Methods for Assessment of Neurotoxicity. In: Ballantyne, B., Ed., Perspectives in Basic and Applied Toxicology, John Wright, London, 1-30. http://dx.doi.org/10.1016/B978-0-7236-0837-0.50005-X
Durrant, C., Tayem, H., Yalcin, B., Cleak, J., Goodstadt, L., Pardo-Manuel de Villena, F., Mott, R. and Iraqi, F.A. (2011) Collaborative Cross Mice and Their Power to Map Host Susceptibility to Aspergillus Fumigatus Infection. Genome Research, 21, 1239-1248. http://genome.cshlp.org/content/21/8/1239.abstract http://dx.doi.org/10.1101/gr.118786.110
Fleischer, S., Sharkey, M., Mealey, K., Ostrander, E.A. and Martinez, M. (2008) Pharmacogenetic and Metabolic Differences between Dog Breeds: Their Impact on Canine Medicine and the Use of the Dog as a Preclinical Animal Model. AAPS Journal, 10, 110-119. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 18446511 http://dx.doi.org/10.1208/s12248-008-9011-1
Herzig, M. and Christofori, G. (2002) Recent Advances in Cancer Research: Mouse Models of Tumorigenesis. Biochimica et Biophysica Acta, 1602, 97-113. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 12020798
Hunter, K., Welch, D.R. and Liu, E.T. (2003) Genetic Background Is an Important Determinant of Metastatic Potential. Nature Genetics, 34, 23-24. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 12721549 http://dx.doi.org/10.1038/ng0503-23b
Ingram, D.K. and Jucker, M. (1999) Developing Mouse Models of Aging: A Consideration of Strain Differences in Age-Related Behavioral and Neural Parameters. Neurobiol Aging, 20, 137-145. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 10537023 http://dx.doi.org/10.1016/S0197-4580(99)00033-0
LeCouter, J.E., Kablar, B., Whyte, P.F., Ying, C. and Rudnicki, M.A. (1998) Strain-Dependent Embryonic Lethality in Mice Lacking the Retinoblastoma-Related p130 Gene. Development, 125, 4669-4679. http://dev.biologists.org/content/125/23/4669.abstract
Lindsay, M.A. (2005) Finding New Drug Targets in the 21st Century. Drug Discovery Today, 10, 1683-1687. http://www.ncbi.nlm.nih.gov/pubmed/16376829 http://dx.doi.org/10.1016/S1359-6446(05)03670-6
Martinez, M., Modric, S., Sharkey, M., Troutman, L., Walker, L. and Mealey, K. (2008) The Pharmacogenomics of P-Glycoprotein and Its Role in Veterinary Medicine. Journal of Veterinary Pharmacology and Therapeutics, 31, 285-300. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 18638289 http://dx.doi.org/10.1111/j.1365-2885.2008.00964.x
Miklos, G.L.G. (2005) The Human Cancer Genome Project—One More Misstep in the War on Cancer. Nature Biotechnology, 23, 535-537. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 15877064 http://dx.doi.org/10.1038/nbt0505-535
Morange, M. (2001) A Successful Form for Reductionism. The Biochemist, 23, 37-39.
Nijhout, H.F. (2003) The Importance of Context in Genetics. American Scientist, 91, 416-423. http://dx.doi.org/10.1511/2003.5.416
Pearson, H. (2002) Surviving a Knockout Blow. Nature, 415, 8-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 11780081 http://dx.doi.org/10.1038/415008a
Raineri, I., Carlson, E.J., Gacayan, R., Carra, S., Oberley, T.D., Huang, T.T. and Epstein, C.J. (2001) Strain-Dependent High-Level Expression of a Transgene for Manganese Superoxide Dismutase Is Associated with Growth Retardation and Decreased Fertility. Free Radical Biology Medicine, 31, 1018-1030. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 11595386 http://dx.doi.org/10.1016/S0891-5849(01)00686-4
Rohan, R.M., Fernandez, A., Udagawa, T., Yuan, J. and D’Amato, R.J. (2000) Genetic Heterogeneity of Angiogenesis in Mice. FASEB Journal, 14, 871-876. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 10783140
Sutter, N.B., Bustamante, C.D., Chase, K., Gray, M.M., Zhao, K., Zhu, L., Padhukasahasram, B., Karlins, E., Davis, S., Jones, P.G., Quignon, P., Johnson, G.S., Parker, H.G., Fretwell, N., Mosher, D.S., Lawler, D.F., Satyaraj, E., Nordborg, M., Lark, K.G., Wayne, R.K. and Ostrander, E.A. (2007) A Single IGF1 Allele Is a Major Determinant of Small Size in Dogs. Science, 316, 112-115. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 17412960 http://dx.doi.org/10.1126/science.1137045
Threadgill, D.W., Dlugosz, A.A., Hansen, L.A., Tennenbaum, T., Lichti, U., Yee, D., LaMantia, C., Mourton, T., Herrup, K., Harris, R.C., et al. (1995) Targeted Disruption of Mouse EGF Receptor: Effect of Genetic Background on Mutant Phenotype. Science, 269, 230-234. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 7618084 http://dx.doi.org/10.1126/science.7618084
Viluksela, M., Duong, T.V., Stahl, B.U., Li, X., Tuomisto, J. and Rozman, K.K. (1996) Toxicokinetics of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) in Two Substrains of Male Long-Evans Rats after Intravenous Injection. Fundamental and Applied Toxicology, 31, 184-191. http://www.sciencedirect.com/science/article/B6WFT-45MGYM7-3V/2/f1408e30b8f4886fa98aaa760f2e64df http://dx.doi.org/10.1006/faat.1996.0090
Potter, N.E., Ermini, L., Papaemmanuil, E., Cazzaniga, G., Vijayaraghavan, G., Titley, I., Ford, A., Campbell, P., Kearney, L. and Greaves, M. (2013) Single-Cell Mutational Profiling and Clonal Phylogeny in Cancer. Genome Research, 23, 2115-2125. http://www.ncbi.nlm.nih.gov/pubmed/24056532 http://dx.doi.org/10.1101/gr.159913.113
Jørgensen, J.T. (2011) A Challenging Drug Development Process in the Era of Personalized Medicine. Drug Discovery Today, 16, 891-897. http://dx.doi.org/10.1016/j.drudis.2011.09.010
(1998) Human Albumin Administration in Critically Ill Patients: Systematic Review of Randomised Controlled Trials. Cochrane Injuries Group Albumin Reviewers. BMJ, 317, 235-240. http://dx.doi.org/10.1136/bmj.317.7153.235
Finfer, S., Bellomo, R., Boyce, N., French, J., Myburgh, J. and Norton, R. (2004) A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit. New England Journal of Medicine, 350, 2247-2256. http://dx.doi.org/10.1056/NEJMoa040232
Weinberg, D. (2012) The Plausibility Problem. http://www.sciencebasedmedicine.org/the-plausibility-problem/
Atwood, K. (2008) Prior Probability: The Dirty Little Secret of “Evidence-Based Alternative Medicine”. http://www.sciencebasedmedicine.org/prior-probability-the-dirty-little-secret-of-evidence-based-alternative-medicine-2/
Orac (2011) Homeopathy and “Plausibility Bias” versus Science. http://scienceblogs.com/insolence/2011/08/24/homeopathy-and-plausibility-bias-versus/
Ioannidis, J.P. (2005) Why Most Published Research Findings Are False. PLoS Medicine, 2, e124. http://www.ncbi.nlm.nih.gov/pubmed/16060722 http://dx.doi.org/10.1371/journal.pmed.0020124
Bayes, T. (1763) An Essay towards Solving a Problem in the Doctrine of Chances. Philosophical Transactions of the Royal Society, 53, 370-418. http://dx.doi.org/10.1098/rstl.1763.0053
Bovens, L. and Hartmann, S. (2004) Bayesian Epistemology. Oxford University Press, New York. http://dx.doi.org/10.1093/0199269750.001.0001
Jørgensen, J.T. (2011) A Challenging Drug Development Process in the Era of Personalized Medicine. Drug Discovery Today, 16, 891-897. http://dx.doi.org/10.1016/j.drudis.2011.09.010
Carrier, R. (2008) “Bayes’ Theorem for Beginners: Formal Logic and Its Relevance to Historical Method—Adjunct Materials and Tutorial”. http://www.richardcarrier.info/CarrierDec08.pdf
Bailey, J. (2008) An Assessment of the Role of Chimpanzees in AIDS Vaccine Research. Alternatives to Laboratory Animals, 36, 381-428.
Kaste, M. (2005) Use of Animal Models Has Not Contributed to Development of Acute Stroke Therapies: Pro. Stroke, 36, 2323-2324. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 16141431 http://dx.doi.org/10.1161/01.STR.0000179037.82647.48
Sena, E., van der Worp, H.B., Howells, D. and Macleod, M. (2007) How Can We Improve the Pre-Clinical Development of Drugs for Stroke? Trends in Neurosciences, 30, 433-439. http://www.ncbi.nlm.nih.gov/pubmed/17765332 http://dx.doi.org/10.1016/j.tins.2007.06.009
Howells, D.W. and Donnan, G.A. (2010) Where Will the Next Generation of Stroke Treatments Come from? PLoS Medicine, 7, Article ID: e1000224. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 20208999 http://dx.doi.org/10.1371/journal.pmed.1000224
Heywood, R. (1981) Target Organ Toxicity. Toxicol Letters, 8, 349-358. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 7302965 http://dx.doi.org/10.1016/0378-4274(81)90125-9
Li, A.P. (2004) Accurate Prediction of Human Drug Toxicity: A Major Challenge in Drug Development. Chemico-Biological Interactions, 150, 3-7. http://dx.doi.org/10.1016/j.cbi.2004.09.008
Spanhaak, S., Cook, D., Barnes, J. and Reynolds, J. (2008) Species Concordance for Liver Injury. From the Safety Intelligence Program Board. http://www.biowisdom.com/files/SIP_Board_Species_Concordance.pdf
LaFollette, H. and Shanks, N. (1995) Two Models of Models in Biomedical Research. Philosophical Quarterly, 45, 141-160. http://dx.doi.org/10.2307/2220412
LaFollette, H. and Shanks, N. (1996) Brute Science: Dilemmas of Animal Experimentation. Routledge, London and New York.
LaFollette, H. and Shanks, N. (1993) Animal Models in Biomedical Research: Some Epistemological Worries. Public Affairs Quarterly, 7, 113-130. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 11652915
Committee on Models for Biomedical Research Board on Basic Biology (1985) Committee on Models for Biomedical Research. Board on Basic Biology. Commission on Life Science. National Research Council. Models for Biomedical Research: A New Perspective. National Academy Press, Washington DC.
Platt, J.R. (1964) Strong Inference: Certain Systematic Methods of Scientific Thinking May Produce Much More Rapid Progress than Others. Science, 146, 347-353. http://www.ncbi.nlm.nih.gov/pubmed/17739513 http://dx.doi.org/10.1126/science.146.3642.347
(2002) Drug Discovery & Development, 35.
Roy, A.S.A. (2012) Stifling New Cures: The True Cost of Lengthy Clinical Drug Trials. Project FDA Report, Manhattan Institute for Policy Research, New York.
Sankar, U. (2005) The Delicate Toxicity Balance in Drug Discovery. The Scientist, 19, 32.
Editorial (2006) An Open Debate. Nature, 444, 789-790. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 17167431
Lazzarini, L., Overgaard, K.A., Conti, E. and Shirtliff, M.E. (2006) Experimental Osteomyelitis: What Have We Learned from Animal Studies about the Systemic Treatment of Osteomyelitis? Journal of Chemotherapy, 18, 451-460. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 17127219 http://dx.doi.org/10.1179/joc.2006.18.5.451